Type 1 diabetes

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes

Diabetes Obes MetabPublished Cross-sectional study

Main finding · Liver stiffnessResult — go to the resultOdds ratio 5.4 95% CI 2.1–13.6

Authors' conclusion

Patients with obesity and T1D had lower liver fat and liver stiffness compared with those patients with T2D, despite similar levels of BMI, a longer duration of diabetes and worse glycaemic control.

Study context

Population
Patients with obesity and T1D or T2D with similar body mass index (BMI); liver fat fraction by MRI and stiffness by elastography
Participants
90 vs 69
Exposure
T1D vs T2D with similar BMI, in patients with obesity
  • T1Dn = 90
  • T2Dn = 69reference
Outcome
Hepatic stiffness and fat fraction
Methodological detailsprospective
  • Prospective

Main finding

Liver stiffness

Odds ratio

5.4

95% CI 2.1–13.6

P < 0.001

By group

T2Dvs T1D
OR 5.4 (95% CI 2.1–13.6); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Liver fat fraction

P < 0.001

MASLD

Fibrosis suggested

Associations with liver fat and stiffness

Aspartate transaminase (AST), ALT, gamma-glutamyl transferase (GGT), TG and android-to-gynoid ratio associated with elevated fat fraction in both cohorts
AST and GGT associated with elevated liver stiffness in both cohorts

Original publication

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Diabetes Obes Metab. Published 10 July 2024. doi:10.1111/dom.15760

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.